Skip Header

 

1 - 25 of 58 results for author:"Kawashima K."Drop in Literature Citations

Customize display Download...

Page of 3 | Next »

Serotonin 1A receptor gene is associated with Japanese methamphetamine-induced psychosis patients.

Kishi T., Tsunoka T., Ikeda M., Kitajima T., Kawashima K., Okochi T., Okumura T., Yamanouchi Y., Kinoshita Y., Ujike H. et al.

Neuropharmacology 0:0-0(2009) · Mapped (11)

Serotonin 1A receptor gene and major depressive disorder: an association study and meta-analysis.

Kishi T., Tsunoka T., Ikeda M., Kawashima K., Okochi T., Kitajima T., Kinoshita Y., Okumura T., Yamanouchi Y., Inada T. et al.

J. Hum. Genet. 0:0-0(2009) · Mapped (4)

Possible association of prokineticin 2 receptor gene (PROKR2) with mood disorders in the Japanese population.

Kishi T., Kitajima T., Tsunoka T., Okumura T., Ikeda M., Okochi T., Kinoshita Y., Kawashima K., Yamanouchi Y., Ozaki N. et al.

Neuromolecular Med. 11:114-122(2009) · Mapped (3)

No association between polymorphisms of neuronal oxide synthase 1 gene (NOS1) and schizophrenia in a Japanese population.

Okumura T., Okochi T., Kishi T., Ikeda M., Kitajima T., Yamanouchi Y., Kinoshita Y., Kawashima K., Tsunoka T., Ujike H. et al.

Neuromolecular Med. 11:123-127(2009) · Mapped (5)

Genetic association analysis of serotonin 2A receptor gene (HTR2A) with bipolar disorder and major depressive disorder in the Japanese population.

Kishi T., Kitajima T., Tsunoka T., Ikeda M., Yamanouchi Y., Kinoshita Y., Kawashima K., Okochi T., Okumura T., Inada T. et al.

Neurosci. Res. 64:231-234(2009) · Mapped (3)

BDNF is not associated with schizophrenia: data from a Japanese population study and meta-analysis.

Kawashima K., Ikeda M., Kishi T., Kitajima T., Yamanouchi Y., Kinoshita Y., Okochi T., Aleksic B., Tomita M., Okada T. et al.

Schizophr. Res. 112:72-79(2009) · Mapped (6)

Genetic association analysis of NRG1 with methamphetamine-induced psychosis in a Japanese population.

Okochi T., Kishi T., Ikeda M., Kitajima T., Kinoshita Y., Kawashima K., Okumura T., Tsunoka T., Inada T., Yamada M. et al.

Prog. Neuropsychopharmacol. Biol. Psychiatry 33:903-905(2009) · Mapped (26)

Association analysis of Group II metabotropic glutamate receptor genes (GRM2 and GRM3) with mood disorders and fluvoxamine response in a Japanese population.

Tsunoka T., Kishi T., Ikeda M., Kitajima T., Yamanouchi Y., Kinoshita Y., Kawashima K., Okochi T., Okumura T., Inada T. et al.

Prog. Neuropsychopharmacol. Biol. Psychiatry 33:875-879(2009) · Mapped (12)

A functional polymorphism in estrogen receptor alpha gene is associated with Japanese methamphetamine induced psychosis.

Kishi T., Ikeda M., Kitajima T., Yamanouchi Y., Kinoshita Y., Kawashima K., Okochi T., Tsunoka T., Okumura T., Inada T. et al.

Prog. Neuropsychopharmacol. Biol. Psychiatry 33:895-898(2009) · Mapped (53)

CLOCK may predict the response to fluvoxamine treatment in Japanese major depressive disorder patients.

Kishi T., Kitajima T., Ikeda M., Yamanouchi Y., Kinoshita Y., Kawashima K., Okochi T., Okumura T., Tsunoka T., Ozaki N. et al.

Neuromolecular Med. 11:53-57(2009) · Mapped (7)

Meta-analysis of association between genetic variants in COMT and schizophrenia: an update.

Okochi T., Ikeda M., Kishi T., Kawashima K., Kinoshita Y., Kitajima T., Yamanouchi Y., Tomita M., Inada T., Ozaki N. et al.

Schizophr. Res. 110:140-148(2009) · Mapped (8)

Association study of clock gene (CLOCK) and schizophrenia and mood disorders in the Japanese population.

Kishi T., Kitajima T., Ikeda M., Yamanouchi Y., Kinoshita Y., Kawashima K., Okochi T., Okumura T., Tsunoka T., Inada T. et al.

Eur Arch Psychiatry Clin Neurosci 259:293-297(2009) · Mapped (7)

Detection of a novel silent deletion, a missense mutation and a nonsense mutation in TCOF1.

Fujioka H., Ariga T., Horiuchi K., Ishikiriyama S., Oyama K., Otsu M., Kawashima K., Yamamoto Y., Sugihara T., Sakiyama Y.

Pediatr Int 50:806-809(2008) · Mapped (7)

Prostate apoptosis response 4 gene is not associated with methamphetamine-use disorder in the Japanese population.

Kishi T., Ikeda M., Kitajima T., Yamanouchi Y., Kinoshita Y., Kawashima K., Inada T., Harano M., Komiyama T., Hori T. et al.

Ann. N. Y. Acad. Sci. 1139:83-88(2008) · Mapped (1)

Alpha4 and beta2 subunits of neuronal nicotinic acetylcholine receptor genes are not associated with methamphetamine-use disorder in the Japanese population.

Kishi T., Ikeda M., Kitajima T., Yamanouchi Y., Kinoshita Y., Kawashima K., Inada T., Harano M., Komiyama T., Hori T. et al.

Ann. N. Y. Acad. Sci. 1139:70-82(2008) · Mapped (11)

Glutamate cysteine ligase modifier (GCLM) subunit gene is not associated with methamphetamine-use disorder or schizophrenia in the Japanese population.

Kishi T., Ikeda M., Kitajima T., Yamanouchi Y., Kinoshita Y., Kawashima K., Inada T., Harano M., Komiyama T., Hori T. et al.

Ann. N. Y. Acad. Sci. 1139:63-69(2008) · Mapped (2)

Genetic association analysis of tagging SNPs in alpha4 and beta2 subunits of neuronal nicotinic acetylcholine receptor genes (CHRNA4 and CHRNB2) with schizophrenia in the Japanese population.

Kishi T., Ikeda M., Kitajima T., Yamanouchi Y., Kinoshita Y., Kawashima K., Okochi T., Inada T., Ozaki N., Iwata N.

J Neural Transm 115:1457-1461(2008) · Mapped (9)

Aberrant trafficking of the high-affinity choline transporter in AP-3-deficient mice.

Misawa H., Fujigaya H., Nishimura T., Moriwaki Y., Okuda T., Kawashima K., Nakata K., Ruggiero A.M., Blakely R.D., Nakatsu F. et al.

Eur. J. Neurosci. 27:3109-3117(2008) · Mapped (20)

No association between tagging SNPs of SNARE complex genes (STX1A, VAMP2 and SNAP25) and schizophrenia in a Japanese population.

Kawashima K., Kishi T., Ikeda M., Kitajima T., Yamanouchi Y., Kinoshita Y., Takahashi N., Saito S., Ohi K., Yasuda Y. et al.

Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B:1327-1331(2008) · Mapped (8)

L347P PINK1 mutant that fails to bind to Hsp90/Cdc37 chaperones is rapidly degraded in a proteasome-dependent manner.

Moriwaki Y., Kim Y.J., Ido Y., Misawa H., Kawashima K., Endo S., Takahashi R.

Neurosci. Res. 61:43-48(2008) · Mapped (1)

Failure to replicate the association between NRG1 and schizophrenia using Japanese large sample.

Ikeda M., Takahashi N., Saito S., Aleksic B., Watanabe Y., Nunokawa A., Yamanouchi Y., Kitajima T., Kinoshita Y., Kishi T. et al.

Schizophr. Res. 101:1-8(2008) · Mapped (26)

Complete genomic structure of the bloom-forming toxic cyanobacterium Microcystis aeruginosa NIES-843.

Kaneko T., Nakajima N., Okamoto S., Suzuki I., Tanabe Y., Tamaoki M., Nakamura Y., Kasai F., Watanabe A., Kawashima K. et al.

DNA Res. 14:247-256(2007) · UniProtKB (5,981)

No association between prostate apoptosis response 4 gene (PAWR) in schizophrenia and mood disorders in a Japanese population.

Kishi T., Ikeda M., Kitajima T., Suzuki T., Yamanouchi Y., Kinoshita Y., Kawashima K., Ozaki N., Iwata N.

Am. J. Med. Genet. B Neuropsychiatr. Genet. 147B:531-534(2008) · Mapped (1)

Sensitive detection of FGFR3 mutations in bladder cancer and urine sediments by peptide nucleic acid-mediated real-time PCR clamping.

Miyake M., Sugano K., Kawashima K., Ichikawa H., Hirabayashi K., Kodama T., Fujimoto H., Kakizoe T., Kanai Y., Fujimoto K. et al.

Biochem. Biophys. Res. Commun. 362:865-871(2007) · Mapped (10)

Enhanced serum antigen-specific IgG1 and proinflammatory cytokine production in nicotinic acetylcholine receptor alpha7 subunit gene knockout mice.

Fujii Y.X., Fujigaya H., Moriwaki Y., Misawa H., Kasahara T., Grando S.A., Kawashima K.

J. Neuroimmunol. 189:69-74(2007) · Mapped (32)

Page of 3 | Next »